ATE551341T1 - Chinuklidincarbonatderivate und medizinische zusammensetzung davon - Google Patents

Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Info

Publication number: ATE551341T1
Authority: AT; Austria
Prior art keywords: medical composition; carbonate derivatives; quinuclidine; quinuclidine carbonate; derivatives
Prior art date: 2008-08-08

Application number

AT09777321T

Other languages

English (en)

Inventor

Gabriele Amari

Maurizio Delcanale

Original Assignee

Chiesi Farma Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-08

Filing date

2009-07-21

Publication date

2012-04-15

2009-07-21 Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE551341T1 publication Critical patent/ATE551341T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

AT09777321T 2008-08-08 2009-07-21 Chinuklidincarbonatderivate und medizinische zusammensetzung davon ATE551341T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08162066A EP2154136A1 (de)	2008-08-08	2008-08-08	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
PCT/EP2009/005272 WO2010015324A1 (en)	2008-08-08	2009-07-21	Quinuclidine carbonate derivatives and medicinal composition thereof

Publications (1)

Publication Number	Publication Date
ATE551341T1 true ATE551341T1 (de)	2012-04-15

Family

ID=40228074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09777321T ATE551341T1 (de)	2008-08-08	2009-07-21	Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Country Status (31)

Country	Link
US (3)	US8039483B2 (de)
EP (2)	EP2154136A1 (de)
JP (1)	JP2011530489A (de)
KR (1)	KR20110044221A (de)
CN (1)	CN102112474B (de)
AR (1)	AR072994A1 (de)
AT (1)	ATE551341T1 (de)
AU (1)	AU2009278306B2 (de)
CA (1)	CA2733380A1 (de)
CO (1)	CO6351790A2 (de)
CY (1)	CY1112724T1 (de)
DK (1)	DK2313404T3 (de)
EA (1)	EA019166B1 (de)
ES (1)	ES2384914T3 (de)
GE (1)	GEP20135744B (de)
HR (1)	HRP20120394T1 (de)
IL (1)	IL211103A (de)
JO (1)	JO2831B1 (de)
MA (1)	MA32622B1 (de)
ME (1)	ME01283A (de)
MX (1)	MX2011001504A (de)
MY (1)	MY156332A (de)
NZ (1)	NZ590987A (de)
PL (1)	PL2313404T3 (de)
PT (1)	PT2313404E (de)
RS (1)	RS52370B (de)
SI (1)	SI2313404T1 (de)
TW (1)	TWI455938B (de)
UA (1)	UA102857C2 (de)
WO (1)	WO2010015324A1 (de)
ZA (1)	ZA201100963B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2230934T3 (da)	2007-12-14	2012-11-26	Aerodesigns Inc	Afgivelse af aerosoliserbare næringsmiddelprodukter
EP2154136A1 (de)	2008-08-08	2010-02-17	CHIESI FARMACEUTICI S.p.A.	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de)	2008-12-23	2010-07-14	CHIESI FARMACEUTICI S.p.A.	Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
DK2560611T3 (en)	2010-04-21	2018-02-26	Chiesi Farm Spa	Process for providing particles with reduced electrostatic charges
RU2569846C2 (ru)	2010-06-22	2015-11-27	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Алкалоидные производные сложных аминоэфиров и включающие их лекарственные композиции
CA2803459A1 (en)	2010-06-22	2011-12-29	Chiesi Farmaceutici S.P.A.	Alkaloid aminoester derivatives and medicinal compositions thereof
KR20130087406A (ko)	2010-06-22	2013-08-06	키에시 파르마슈티시 엣스. 피. 에이.	알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물
EP2621494B1 (de) *	2010-09-30	2018-11-07	Chiesi Farmaceutici S.p.A.	Verwendung von magnesiumstearat in trockenpulverfomulierungen zur inhalation
CA2815035A1 (en) *	2010-10-20	2012-04-26	Chiesi Farmaceutici S.P.A.	Carbonate derivatives for the treatment of cough
WO2012069275A1 (en)	2010-11-26	2012-05-31	Chiesi Farmaceutici S.P.A.	Glycine derivatives and their use as muscarinic receptor antagonists
MY173998A (en) *	2011-03-18	2020-03-03	Genzyme Corp	Glucosylceramide synthase inhibitors
KR20140019409A (ko)	2011-04-29	2014-02-14	키에시 파르마슈티시 엣스. 피. 에이.	알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물
RU2628082C2 (ru)	2011-12-30	2017-08-14	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Хинуклидиновые эфиры 1-азагетероциклилуксусной кислоты в качестве антимускариновых средств, способ их получения и их лекарственные композиции
JOP20130273B1 (ar)	2012-09-11	2021-08-17	Genzyme Corp	مثبطات انزيم (سينثاز) غلوكوسيل سيراميد
US9427376B2 (en)	2013-10-10	2016-08-30	Chiesi Farmaceutici S.P.A.	Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
PT3920912T (pt)	2019-02-04	2025-09-09	Genzyme Corp	Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs)
EP4100009A1 (de)	2020-02-03	2022-12-14	Genzyme Corporation	Verfahren zur behandlung neurologischer symptome im zusammenhang mit lysosomalen speicherkrankheiten
CA3186766A1 (en)	2020-07-24	2022-01-27	Danielle Combessis	Pharmaceutical compositions comprising venglustat

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
NZ526580A (en)	2000-12-22	2005-04-29	Almirall Prodesfarma Ag	Quinuclidine carbamate derivatives and their use as M3 antagonists
EP1383730A2 (de) *	2001-04-03	2004-01-28	Aryx Therapeutics	Anticholinerge verbindungen und anwendungsverfahren
RS52522B (sr)	2001-12-20	2013-04-30	Chiesi Farmaceutici S.P.A.	Derivati 1-alkil-1-azoniabiciklo/2.2.2./oktan karbamata i njihova upotreba kao antagonista muskarinskih receptora
EP1882691A1 (de)	2006-07-26	2008-01-30	CHIESI FARMACEUTICI S.p.A.	Chinuclidinderivate als M3 Antagonisten
EP2154136A1 (de)	2008-08-08	2010-02-17	CHIESI FARMACEUTICI S.p.A.	Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de)	2008-12-23	2010-07-14	CHIESI FARMACEUTICI S.p.A.	Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
BR112012032330A2 (pt)	2010-06-22	2016-11-08	Chiesi Farma Spa	formulação em pó seco inalável, uso de uma formulação em pó seco, inalador de pó seco e embalagem
CA2815035A1 (en)	2010-10-20	2012-04-26	Chiesi Farmaceutici S.P.A.	Carbonate derivatives for the treatment of cough
US20120220557A1 (en)	2011-02-17	2012-08-30	Chiesi Farmaceutici S.P.A.	Liquid propellant-free formulation comprising an antimuscarinic drug
KR20140019409A (ko)	2011-04-29	2014-02-14	키에시 파르마슈티시 엣스. 피. 에이.	알칼로이드 에스텔 및 카바메이트 유도체와 그들의 의약조성물

2008
- 2008-08-08 EP EP08162066A patent/EP2154136A1/de not_active Withdrawn
2009
- 2009-07-21 SI SI200930266T patent/SI2313404T1/sl unknown
- 2009-07-21 ME MEP-2011-24A patent/ME01283A/me unknown
- 2009-07-21 CA CA2733380A patent/CA2733380A1/en not_active Abandoned
- 2009-07-21 EA EA201100161A patent/EA019166B1/ru not_active IP Right Cessation
- 2009-07-21 AT AT09777321T patent/ATE551341T1/de active
- 2009-07-21 EP EP09777321A patent/EP2313404B1/de active Active
- 2009-07-21 ES ES09777321T patent/ES2384914T3/es active Active
- 2009-07-21 CN CN200980130187.4A patent/CN102112474B/zh not_active Expired - Fee Related
- 2009-07-21 GE GEAP200912093A patent/GEP20135744B/en unknown
- 2009-07-21 HR HRP20120394AT patent/HRP20120394T1/hr unknown
- 2009-07-21 MY MYPI2011000542A patent/MY156332A/en unknown
- 2009-07-21 RS RS20120262A patent/RS52370B/sr unknown
- 2009-07-21 DK DK09777321.2T patent/DK2313404T3/da active
- 2009-07-21 JP JP2011521454A patent/JP2011530489A/ja active Pending
- 2009-07-21 MX MX2011001504A patent/MX2011001504A/es active IP Right Grant
- 2009-07-21 KR KR1020117002974A patent/KR20110044221A/ko not_active Ceased
- 2009-07-21 UA UAA201101383A patent/UA102857C2/ru unknown
- 2009-07-21 PL PL09777321T patent/PL2313404T3/pl unknown
- 2009-07-21 WO PCT/EP2009/005272 patent/WO2010015324A1/en not_active Ceased
- 2009-07-21 PT PT09777321T patent/PT2313404E/pt unknown
- 2009-07-21 NZ NZ590987A patent/NZ590987A/xx not_active IP Right Cessation
- 2009-07-21 AU AU2009278306A patent/AU2009278306B2/en not_active Ceased
- 2009-07-30 US US12/512,262 patent/US8039483B2/en active Active
- 2009-08-06 TW TW098126682A patent/TWI455938B/zh not_active IP Right Cessation
- 2009-08-06 JO JO2009296A patent/JO2831B1/en active
- 2009-08-07 AR ARP090103053A patent/AR072994A1/es unknown
2011
- 2011-02-07 IL IL211103A patent/IL211103A/en not_active IP Right Cessation
- 2011-02-07 ZA ZA2011/00963A patent/ZA201100963B/en unknown
- 2011-02-07 CO CO11013721A patent/CO6351790A2/es active IP Right Grant
- 2011-03-08 MA MA33683A patent/MA32622B1/fr unknown
- 2011-08-26 US US13/219,109 patent/US8440690B2/en not_active Expired - Fee Related
- 2011-09-14 US US13/232,415 patent/US8404712B2/en not_active Expired - Fee Related
2012
- 2012-05-11 CY CY20121100443T patent/CY1112724T1/el unknown

Also Published As

Publication number	Publication date
NZ590987A (en)	2012-11-30
UA102857C2 (en)	2013-08-27
EP2313404B1 (de)	2012-03-28
CO6351790A2 (es)	2011-12-20
IL211103A (en)	2014-04-30
US20100035922A1 (en)	2010-02-11
US20110319444A1 (en)	2011-12-29
MY156332A (en)	2016-02-15
US20120004258A1 (en)	2012-01-05
SI2313404T1 (sl)	2012-07-31
HK1156032A1 (en)	2012-06-01
EP2154136A1 (de)	2010-02-17
CA2733380A1 (en)	2010-02-11
WO2010015324A1 (en)	2010-02-11
EA019166B1 (ru)	2014-01-30
US8039483B2 (en)	2011-10-18
HRP20120394T1 (hr)	2012-06-30
AR072994A1 (es)	2010-10-06
IL211103A0 (en)	2011-04-28
PT2313404E (pt)	2012-07-02
ZA201100963B (en)	2012-05-30
JP2011530489A (ja)	2011-12-22
TW201011022A (en)	2010-03-16
PL2313404T3 (pl)	2012-09-28
AU2009278306B2 (en)	2014-06-26
MX2011001504A (es)	2011-03-29
CN102112474A (zh)	2011-06-29
EP2313404A1 (de)	2011-04-27
DK2313404T3 (da)	2012-06-04
AU2009278306A1 (en)	2010-02-11
ES2384914T3 (es)	2012-07-13
GEP20135744B (en)	2013-02-11
EA201100161A1 (ru)	2011-10-31
JO2831B1 (en)	2014-09-15
TWI455938B (zh)	2014-10-11
US8404712B2 (en)	2013-03-26
MA32622B1 (fr)	2011-09-01
CY1112724T1 (el)	2016-02-10
KR20110044221A (ko)	2011-04-28
CN102112474B (zh)	2014-01-29
ME01283A (me)	2013-06-20
US8440690B2 (en)	2013-05-14
RS52370B (sr)	2012-12-31

Publication	Publication Date	Title
ATE551341T1 (de)	2012-04-15	Chinuklidincarbonatderivate und medizinische zusammensetzung davon
LTPA2018005I1 (lt)	2018-02-12	Farmacinė kompozicija
PT2448582T (pt)	2017-07-10	Compostos e composições terapêuticas
BRPI0918206A2 (pt)	2015-12-08	derivados de animoéster e composição medicinal destes
PT2567707T (pt)	2016-12-27	Composição de péptidos associados a tumores e vacina anticancro relacionada
BRPI0906980A2 (pt)	2015-07-21	Composição de derivados e maleatados
EP2515946A4 (de)	2015-10-07	Nanokonjugate und nanokonjugatformulierungen
ATE488227T1 (de)	2010-12-15	Feste zubereitung mit alogliptin und pioglitazon
BR112012001532A2 (pt)	2019-09-24	"substituída azolesulfonamides benzoimid e indolesulfonamides substituído como potenciadores mglur4"
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0905715A2 (pt)	2015-07-14	Composição farmacêutica e kit de componentes
BRPI0819232A2 (pt)	2016-11-01	composto heterocíclico e composição farmacêutica do mesmo
BRPI0905369A2 (pt)	2015-06-30	Composição farmacêutica, composição e kit compartimentado
EP2236149A4 (de)	2012-12-26	Medizinische zusammensetzung
DE602008001981D1 (de)	2010-09-09	Stellung und therapeutische verwendung
EP2144635A4 (de)	2013-03-20	Sterilisierende zusammensetzung
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
EP2298365A4 (de)	2013-01-23	Medizinische zusammensetzung und medizinisches kit
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
DK2391351T3 (da)	2014-12-01	Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
ATE536893T1 (de)	2011-12-15	Zibotentan zusammensetzung mit mannitol und mikrokristalliner zellulose
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
ATE499368T1 (de)	2011-03-15	Chinolonverbindung und pharmazeutische zusammensetzung